Options
Hormone therapy and the medical encounter: a qualitative analysis of women's experiences
Alternative Title
HT and the medical encounter: a qualitative analysis of women's experiences
Date Issued
2010-03
Date Available
2013-02-11T17:14:51Z
Abstract
Objective: The aim of this article was to explore women's experiences in biomedical consultations for menopause symptoms, with a particular focus on how hormone therapy (HT) featured during the encounter.
Methods: Semistructured interviews were conducted with 39 women, and data were analyzed using a qualitative strategy referred to as Thematic Networks.
Results: Several participants whose menopause started before the period of the HT "scares" described being "put on" HT as a matter of course, even when their symptoms were mild. By contrast, some of those presenting in the more recent time period with what they deemed to be severe symptoms were more likely to describe scenarios whereby they pressured their physicians for an HT prescription. Once on HT, participants were found to be far from passive recipients of a biomedical "treatment" but rather embarked on an active dialogue with themselves about how to manage the distressing aspects of menopause.
Conclusions: Using HT did not tend to spell a transition to biomedical advocacy, despite its reported effectiveness in moderating bodily distresses. Rather, HT tended to retain a tentative status as a temporary relief and not a long-term panacea.
Type of Material
Journal Article
Publisher
Lippincott Williams & Wilkins
Journal
Menopause: Journal of the North American Menopause Society
Volume
17
Issue
2
Start Page
344
End Page
350
Copyright (Published Version)
2010 The North American Menopause Society
Language
English
Status of Item
Peer reviewed
This item is made available under a Creative Commons License
File(s)
Owning collection
Scopus© citations
9
Acquisition Date
Mar 28, 2024
Mar 28, 2024
Views
1749
Last Month
2
2
Acquisition Date
Mar 28, 2024
Mar 28, 2024
Downloads
331
Last Week
1
1
Last Month
11
11
Acquisition Date
Mar 28, 2024
Mar 28, 2024